1. Inappropriate prescribing: a systematic overview of published assessment tools

   • Carole P. Kaufmann
   • Regina Tremp
   • Markus L. Lampert

   Review Article 10 September 2013 Pages: 1 - 11

   

2. Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes

   • Yaguo Zheng
   • Tao Yang
   • Changming Xiong

   Review Article 12 September 2013 Pages: 13 - 21

   

3. Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature

   • A. P. Cossu
   • M. Musu
   • G. Finco

   Review Article 11 September 2013 Pages: 23 - 28

   

4. Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

   • Stephen Weller
   • Julie Borland
   • Stephen C. Piscitelli

   Clinical Trial Open access 06 October 2013 Pages: 29 - 35

   

5. Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates

   • Lynda J. Haberer
   • Iain McSherry
   • Linda McCarthy

   Clinical Trial Open access 08 October 2013 Pages: 37 - 45

   

6. Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

   • Dhakchinamoorthi Krishna Kumar
   • Deepak Gopal Shewade
   • Chandrasekaran Adithan

   Pharmacoeconomics 10 September 2013 Pages: 47 - 56

   

7. The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects

   • Xiujun Wu
   • Li Yuan
   • Tao Guo

   Pharmacokinetics and Disposition 28 September 2013 Pages: 57 - 63

   

8. Importance of hematocrit for a tacrolimus target concentration strategy

   • Elisabet Størset
   • Nick Holford
   • Anders Åsberg

   Pharmacokinetics and Disposition Open access 27 September 2013 Pages: 65 - 77

   

9. Negative clinical outcomes of medication resulting in emergency department visits

   • María Isabel Baena
   • Paloma C. Fajardo
   • Fernando Martínez-Martínez

   Pharmacoepidemiology and Prescription 03 October 2013 Pages: 79 - 87

   

10. Risk factors for non-adherence to antidepressant treatment in patients with mood disorders

    • Carlos De las Cuevas
    • Wenceslao Peñate
    • Emilio J. Sanz

    Pharmacoepidemiology and Prescription 08 September 2013 Pages: 89 - 98

11. Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study

    • D. Macías Saint-Gerons
    • C. de la Fuente Honrubia
    • F. Catalá-López

    Pharmacoepidemiology and Prescription 24 September 2013 Pages: 99 - 108

    

12. Do educational meetings and group detailing change adherence to drug formularies in hospitals? A cluster randomized controlled trial

    • Hanne T. Plet
    • Lene J. Kjeldsen
    • Jesper Hallas

    Pharmacoepidemiology and Prescription 29 September 2013 Pages: 109 - 116

    

13. Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatment

    • Diana M. Rydberg
    • Lennart Holm
    • Rickard E. Malmström

    Pharmacoepidemiology and Prescription 06 October 2013 Pages: 117 - 126